Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Assets (2024 - 2025)

Historic Return on Assets for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to 0.21%.

  • CG Oncology's Return on Assets fell 800.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.18% for FY2024, which is N/A changed from last year.
  • Per CG Oncology's latest filing, its Return on Assets stood at 0.21% for Q3 2025, which was down 800.0% from 0.18% recorded in Q2 2025.
  • CG Oncology's Return on Assets' 5-year high stood at 0.11% during Q2 2024, with a 5-year trough of 0.21% in Q3 2025.